Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Neos Therapeutics resubmits NDA for FDA review of amphetamine XR-ODT
Neos Therapeutics announced that it has resubmitted a New Drug Application to the FDA for its amphetamine XR orally disintegrating tablet product candidate, NT‐0202, for the treatment of ADHD.
July 30, 2015
More...
Email This Page
to a Friend
Print This
Page